• 1. School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong 261000, P. R. China;
  • 2. Department of Spine Surgery, Liaocheng People’s Hospital, Beijing Jishuitan Hospital Liaocheng Branch, Liaocheng, Shandong 252000, P. R. China;
LIU Yanbin, Email: 15315388294@163.com
Export PDF Favorites Scan Get Citation

Bone malignancies exhibit the characteristics of high incidence, poor prognosis, and strong chemoresistance. Exosomal microRNAs can regulate the proliferation of bone malignant cells, improve chemoresistance, influence cell communication and the microenvironment, and have significant potential in the diagnosis and treatment of bone malignancies. Due to their stability, exosomal microRNAs can serve as non-invasive biomarkers for diagnosis and prognosis. However, their widespread application in clinical settings requires standardized research. This review summarizes the progress of exosomal microRNA research in various bone malignancies including osteosarcoma, chondrosarcoma, Ewing sarcoma, and fibrosarcoma, to provide new theoretical foundations and perspectives for the field.

Citation: LI Linyang, ZHANG Yongbo, ZHANG Yujie, HUO Lukuan, LIU Yanbin. Research progress and prospects of exosomal microRNAs in bone malignancies. West China Medical Journal, 2024, 39(12): 1978-1982. doi: 10.7507/1002-0179.202410007 Copy

Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved

  • Previous Article

    Research progress of mitochondrial quality control in leukemia
  • Next Article

    Clinical application research progress of skin chronic wound dressings based on nanomaterials